Multifocal motor neuropathy: long-term clinical and electrophysiological features of the disease
Open Access
- 20 February 2024
- journal article
- research article
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 16 (1) , 42-48
Abstract
Little attention has been paid abroad to the problem of the long-term course of multifocal motor neuropathy (MMN). In our country, catamnestic studies of MMN have not been conducted at all. However, the results of such an analysis are extremely important for understanding the course and prognosis of the disease.Objective: to analyse the clinical and neurophysiological data of patients with MMN with a disease duration of more than 5 years.Material and methods. The study included 28 patients with MMN: 9 women (32%) and 19 men (68%); the median age at admission was 50 [44; 56] years; the median disease duration was 10 [8; 13] years. Medical documentation, medical history, complaints, neurological examination results (scored on the MRC and INCAT scales) and results of electroneuromyography (ENMG) of the long nerves of the hands were analysed.Results. The median time between onset of the disease and diagnosis was 5.5 [2; 10] years. Paresis 0.05). An objective assessment of sensory disorders revealed no changes when testing tactile, pain and temperature sensitivity, while half of the cases (14/28; 50%) showed a disturbance of vibration sensitivity in the lower extremities. The ENMG examination was consistent with the electrophysiological criteria of the disease, one third of the patients showed significant secondary damage to the axons of the motor fibers of the hand nerves, and in half of the cases a slight impairment of the axons of the sensory fibers was registered.Conclusion. MMN is a curable disease. Unfortunately, our retrospective analysis showed that in the Russian Federation there are problems with its diagnosis and quality care of this category of patients. Late diagnosis, delayed start of treatment and non-compliance with the schedule of pathogenetic therapy lead to persistent disability of patients.Keywords
This publication has 15 references indexed in Scilit:
- Immunoglobulin for multifocal motor neuropathyCochrane Database of Systematic Reviews, 2022
- Standards for quantification of EMG and neurographyClinical Neurophysiology, 2019
- Electrodiagnosis in Diseases of Nerve and Muscle2013
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revisionJournal of the Peripheral Nervous System, 2010
- Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition?Journal of Neurology, 2009
- Sensory loss in multifocal motor neuropathy: A clinical and electrophysiological studyMuscle & Nerve, 2009
- Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patientsJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Multifocal Motor Neuropathy with Conduction Block: Current Issues in Diagnosis and TreatmentSeminars in Neurology, 2003
- Multifocal motor neuropathy: long‐term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatmentBrain, 2002
- Long term follow up of multifocal motor neuropathy with conduction block under treatment.Journal of Neurology, Neurosurgery & Psychiatry, 1997